NEW YORK and MELBOURNE, Australia, May 27, 2014 -- Regenerative medicine company Mesoblast Limited today announced that it is bringing forward plans for its commercial manufacturing operations in line with anticipated product launches in the United States and other major markets.
http://ift.tt/1nyJF1k
http://ift.tt/1nyJF1k
No comments:
Post a Comment